← Leaderboards
Beverly Mock
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Plasmacytoma”
- Michael D Cole · Princeton University$4,619,708
- Yong Li · Baylor College Of Medicine$3,740,029
- Anindya Bagchi · University Of Minnesota$1,672,510
- Siegfried Janz · University Of Iowa$1,499,598
- Mark T Groudine · Fred Hutchinson Cancer Research Center$1,487,312
- Janet M. Stavnezer · Univ Of Massachusetts Med Sch Worcester$1,387,007
Research focus
PlasmacytomaProteinsIn VivoTumorPlasma Cell NeoplasmMalignant NeoplasmsCellsCell LineSirolimusPredispositionGenesResistanceMultiple MyelomaMapsComplex Genetic TraitPhosphorylationResponseGrowthInhibitor/AntagonistProto-Oncogene Proteins C-AktMouse StrainsGenetic Predisposition To DiseaseTumor Cell LineSignal Transduction
Grant awards (52)
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$698,441
ZIA · FY2025 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$698,441
ZIA · FY2025 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$749,110
ZIA · FY2024 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$749,110
ZIA · FY2024 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$30,576
ZIA · FY2024 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$790,003
ZIA · FY2023 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$711,004
ZIA · FY2023 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$79,001
ZIA · FY2023 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$783,832
ZIA · FY2022 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$705,449
ZIA · FY2022 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$78,383
ZIA · FY2022 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$769,133
ZIA · FY2021 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$692,220
ZIA · FY2021 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$76,913
ZIA · FY2021 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$900,771
ZIA · FY2020 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$525,449
ZIA · FY2020 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$75,064
ZIA · FY2020 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$960,380
ZIA · FY2019 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$560,222
ZIA · FY2019 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$80,032
ZIA · FY2019 · CA · contact PI
Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)$899,620
ZIA · FY2018 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$449,811
ZIA · FY2018 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$149,937
ZIA · FY2018 · CA · contact PI
Preclinical Testing of HDAC, mTOR and MYC Inhibitors$695,826
ZIA · FY2017 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$506,056
ZIA · FY2017 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$63,257
ZIA · FY2017 · CA · contact PI
Preclinical Testing of HDAC, mTOR and MYC Inhibitors$571,244
ZIA · FY2016 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$415,450
ZIA · FY2016 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$51,932
ZIA · FY2016 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$457,057
ZIA · FY2015 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$406,274
ZIA · FY2015 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$152,353
ZIA · FY2015 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$470,407
ZIA · FY2014 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$418,140
ZIA · FY2014 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$156,802
ZIA · FY2014 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$393,001
ZIA · FY2013 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$393,001
ZIA · FY2013 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$196,500
ZIA · FY2013 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$430,742
ZIA · FY2012 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$430,742
ZIA · FY2012 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$215,370
ZIA · FY2012 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$439,729
ZIA · FY2011 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$329,797
ZIA · FY2011 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$329,797
ZIA · FY2011 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$433,016
ZIA · FY2010 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$324,762
ZIA · FY2010 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$324,762
ZIA · FY2010 · CA · contact PI
The Genetics of Susceptibility to Mouse Plasma Cell Tumors$448,310
ZIA · FY2009 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$336,233
ZIA · FY2009 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$336,233
ZIA · FY2009 · CA · contact PI
Preclinical Testing of HDAC and mTOR Inhibitors$304,680
Z01 · FY2008 · CA · contact PI
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1$304,680
Z01 · FY2008 · CA · contact PI